Box News

Topical steroid withdrawal happens when skin that has been exposed to regular, often high-potency steroid creams for weeks to months reacts badly after the medicine is stopped. Instead of simply returning to the baseline rash, the skin can turn intensely red, burn, itch, peel, swell, and sometimes weep. This pattern of symptoms is what patients and many clinicians call topical steroid withdrawal (also called red skin syndrome). The condition is increasingly reported, but how often it happens and exactly why it happens are still being studied. (NCBI)

One simple way to understand the basic biology is to think about what steroids do to normal skin. Topical corticosteroids narrow (constrict) the tiny blood vessels in the skin and strongly suppress local inflammation and immune activity. When the steroid is stopped after long or heavy use, those blood vessels can rebound — they widen quickly and excessively — which causes the sudden, bright redness and a burning feeling. Research points to increased release of nitric oxide and other signals that drive this rebound vasodilation as an important part of the picture. (DermNet®)

Another key mechanism involves changes inside the skin’s cells. Steroids act through glucocorticoid receptors to change which genes are switched on or off. Prolonged steroid exposure can alter receptor levels and behaviour, and it may suppress the skin’s own ability to make cortisol locally. When the external steroid is removed, the cells are left out of balance: normal control systems are damped or dysregulated, and inflammatory pathways can surge back in a disordered way. This receptor and cellular dysregulation is one reason the rebound is often more severe or differently patterned than the original rash. (Springer Nature)

Long steroid use also damages the skin barrier and the local ecosystem. Repeated application thins the skin, impairs normal repair, and changes the microbiome (the mix of bacteria and other microbes on the skin). Those changes make the skin more prone to irritation, infection, and prolonged inflammation once steroids stop. Some recent studies also suggest deeper metabolic effects — for example, shifts in lipids and mitochondrial function — that may help explain why recovery can be slow and why symptoms sometimes include widespread sensitivity, sweating, or other systemic complaints. But these newer ideas are still under investigation. (PMC)

Who is most likely to get withdrawal and how long it lasts depends on several things: the steroid’s strength, how often and how long it was used, where on the body it was applied (areas like the face and scrotum are especially vulnerable), and individual sensitivity. For some people the worst symptoms begin within days to weeks of stopping; for others recovery can take many months or even years. Because research is ongoing, clinicians don’t all agree on diagnostic criteria or the best treatment, and some experts caution that not every red rash after stopping steroids is TSW — distinguishing it from a flare of the original disease can be hard. (NCBI)

In plain terms: topical steroid withdrawal appears to be a mix of rebound blood-vessel overreaction, disturbed steroid signalling inside skin cells, and a damaged skin barrier and microbiome — all of which combine to produce intense, often long-lasting symptoms after stopping prolonged topical steroid use. Because the science is still developing and management can be complicated, anyone who suspects they have TSW should discuss it with a dermatologist so they can get an accurate diagnosis and a safe plan for recovery. (journals.sagepub.com)

Topical steroid withdrawal is mainly associated with topical (skin-applied) corticosteroids.

Oral (pill) or intravenous corticosteroids can cause systemic withdrawal if stopped suddenly after long use (due to adrenal suppression), but they do not cause topical steroid withdrawal of the skin in the same way. The skin-specific rebound reactions seen in TSW are linked to long-term local steroid exposure and its effects on skin blood vessels, receptors, and barrier function.

(Source : ChatGPT)

Yes — corticosteroids can help common skin problems like eczema and psoriasis. Applied to the skin as creams or ointments, or given as pills or injections in more severe cases, they reduce the immune-driven inflammation that causes redness, swelling, itching and the scaly patches typical of these conditions. For many people a short course of a topical steroid will calm a flare quickly, but steroids do not cure the underlying condition — they control symptoms while other treatments and skin care keep the problem quieter. (NCBI)

Topical steroids come in different strengths and forms so the doctor or dermatologist can match the medicine to the problem and the part of the body being treated. Ointments and creams are used directly on affected skin; stronger (potent) steroids are usually saved for thick plaques on the arms or legs, while low-potency steroids are preferred for delicate areas such as the face or genitals. When skin disease is widespread or severe, a specialist may use systemic steroids (pills or injections) short-term or other systemic drugs under close supervision. (Newcastle Hospitals NHS Foundation Trust)

While very effective, steroids also carry risks when used incorrectly or for too long. Local side effects include thinning of the skin, stretch marks, easy bruising, visible small blood vessels, pigmentation changes, and a higher chance of local infections. Using large amounts of potent topical steroids over wide areas, or prolonged high-dose systemic steroids, can also cause effects elsewhere in the body, including suppression of your natural hormone production. Stopping long or heavy steroid use suddenly can lead to problems, and some people experience a difficult rebound called topical steroid withdrawal after long-term, frequent facial or body use. (AAFP)

Because of these risks, modern skin care with steroids follows simple rules: use the mildest steroid that controls the flare, limit how long and how much you apply, avoid applying potent steroids to thin or sensitive skin, and always pair them with regular moisturising (emollients). If eczema or psoriasis is frequent or severe, doctors will often add or switch to steroid-sparing options such as topical calcineurin inhibitors, newer non-steroidal creams, phototherapy, or targeted systemic treatments (including biologic medicines) that control disease with fewer steroid-related harms. Regular follow-up with a clinician helps pick the right strength and schedule and watches for side effects. (nationaleczema.org)

In plain terms: steroids are a very useful tool to quiet down itchy, inflamed skin quickly, but they must be used carefully and as part of an overall plan that includes skin moisturising and, when needed, safer long-term alternatives. If you’re prescribed a steroid cream or tablet, it’s reasonable to ask the prescriber which potency, how long to use it, whether the area is safe for that steroid, and what follow-up or steroid-sparing options exist. (nhs.uk)

Why Corticosteroids Relieve Skin Flares but Don’t Cure Them

When I wrote “steroids do not cure the underlying condition — they control symptoms,” I meant that corticosteroids calm down the visible and felt parts of skin diseases (the redness, swelling, itching and flaking) but usually do not remove the root causes that make the problem come back.

Take eczema: the core problems are a weaker skin barrier and an over-reactive immune response to small triggers. A steroid cream turns off the immune flare and quickly soothes the itching and redness, but it does not rebuild the skin’s natural protective layer or stop the immune system from being sensitive in the future. So once the steroid is stopped, the same vulnerability and triggers can cause the rash to return unless the barrier is repaired with regular moisturiser and other longer-term measures.

Psoriasis is different in detail but similar in principle. It is driven by abnormal immune signals that tell skin cells to divide too quickly. Steroids reduce those immune signals and slow the visible scaly plaques, but they don’t permanently reset the immune process that drives the excessive cell turnover. That means plaques often recur when steroids are withdrawn, especially if steroids are used alone for a long time.

Because steroids act fast but don’t fix underlying causes, modern treatment plans pair them with other strategies that address root problems or reduce the need for continuous steroid use. For eczema that means daily emollients to restore the barrier, identifying and avoiding triggers, and sometimes non-steroid topical medicines that modify immune activity. For psoriasis, doctors may use light therapy or systemic drugs (including targeted biologic medicines) that act on the underlying immune pathways and can produce longer-lasting control.

There are practical consequences of this “symptom control” role. Short, targeted steroid use often gives big benefit with acceptable risk, but long-term or inappropriate use can create side effects and paradoxical issues like rebound flares or steroid dependence of the skin. That is why clinicians aim to use the lowest effective potency, for the shortest needed period, and to combine steroids with steroid-sparing treatments and preventive care.

In plain terms: think of steroids as a powerful fire extinguisher for a flare — critical when flames are high — but not a reconstruction crew that fixes the wiring that started the fire. To keep the problem down over time you usually need additional tools that repair and modify the underlying condition, along with careful medical guidance.

(Source : ChatGPT)

Corticosteroids can affect the eye in two main, clinically important ways: they can make the lens cloudy (a cataract), especially a type called a posterior subcapsular cataract, and they can raise the pressure inside the eye (ocular hypertension), which — if it lasts — can damage the optic nerve and cause glaucoma. These effects are well described and can occur after many kinds of steroid use: eyedrops, injections around or into the eye, pills, and even high-dose inhaled or injected steroids. (CNIB)

Why cataracts happen is not completely nailed down, but the simplest way to think about it is that steroids change how lens cells behave and how lens proteins are maintained. The lens is a transparent, tightly organised structure that depends on precise protein chemistry and active maintenance by lens epithelial cells. Steroids interact with receptors in these cells and can alter gene activity, protein processing, and the balance of growth factors and antioxidants in the eye. Over time those changes can produce abnormal protein clumping or cell changes in the rear part of the lens, leading to the typical “posterior subcapsular” clouding seen with steroid-related cataracts. Because the exact chain of events is complex, scientists describe several possible mechanisms rather than one single cause. (PubMed)

The way steroids raise eye pressure is better understood. Fluid inside the front of the eye is normally drained through a sponge-like structure called the trabecular meshwork. Steroids change the behavior of the cells in that meshwork: they change the proteins those cells make, encourage accumulation of extracellular material, alter the cell skeleton, and can increase expression of particular proteins linked to impaired drainage. When outflow is reduced, the fluid builds up and intraocular pressure (IOP) rises. Some people are genetically or biologically more sensitive to this effect and respond with large pressure rises, while others have only small changes. Prolonged high pressure can damage the optic nerve and produce glaucoma. (PMC)

Who is most at risk, and how fast it happens, depends on several things: the strength and form of the steroid, how it is given, the dose and duration, and individual susceptibility. Potent topical eye steroids, injections into or near the eye, and prolonged high-dose oral or injected steroids carry higher risk than short courses or low-dose inhaled/nasal steroids (though even inhaled steroids at high doses have been linked to pressure rises). People with a personal or family history of glaucoma, very nearsighted people, children, and people with certain systemic conditions can be more likely to develop a significant pressure rise. Cataracts from steroids typically develop over months to years of exposure, while pressure rises can sometimes be seen within weeks to months and occasionally even sooner after an intraocular steroid injection. (Moran CORE)

The good news is that many pressure rises are detectable and manageable if patients are monitored. Eye pressure often falls back toward normal after the steroid is stopped, and pressure-lowering eye drops — or in persistent cases laser or surgery — can control IOP. Cataracts, however, do not reverse when the steroid is stopped; they may progress and eventually need cataract surgery to restore clear vision. Because early pressure rises usually cause no symptoms, clinicians advise a baseline eye check before or soon after starting long-term or high-dose steroid therapy and repeated checks while treatment continues; intravitreal steroid implants or injections often have specific schedules for IOP checks (for example at 1 week, then 2 weeks, then monthly for several months) because of the known risk pattern. Stopping or switching to less-potent or shorter-acting steroid preparations, using steroid-sparing alternatives when possible, and choosing agents designed to lower ocular side effects can all reduce risk. (Glaucoma Today)

In plain terms: corticosteroids can change cell behaviour in the lens and the drainage channels of the eye. Those changes cause the lens to become cloudy over time and can block fluid outflow, raising pressure quickly in some people. That’s why doctors try to use the lowest effective steroid dose for the shortest time, choose the safest formulation when the eye is at risk, and check eye pressure and vision at appropriate intervals while someone is on ongoing steroid therapy. If you or someone you care for is prescribed repeated or strong steroids, mention eye checks to the prescriber and consider a referral to an eye specialist for baseline and follow-up exams. (CNIB)

(Source : ChatGPT)

Corticosteroids can cause side effects because they act like powerful versions of the body’s natural stress hormone and change how many cells in the body behave. When you take a corticosteroid pill, get an injection, or use a high-dose inhaler, the drug reaches many tissues and fits into “glucocorticoid” receptors inside cells. Once the drug is inside a cell and attached to that receptor, it moves into the cell’s control center (the nucleus) and changes which genes are turned on or off. Those gene changes reduce inflammation and calm the immune system, which is why corticosteroids are so effective — but the same gene changes also alter normal processes such as how the body handles sugar, protein, fat, salt, and bone, and that leads to side effects.

One common pathway to side effects is immune suppression. By turning down immune activity, corticosteroids make it easier to control autoimmune inflammation or allergic reactions, but they also make it easier for infections to take hold or to become more severe. That is why people on higher doses or long courses of steroids have a higher risk of infections and why doctors watch for signs of illness while someone is taking them.

Corticosteroids also change metabolism. They increase the liver’s production of glucose and reduce the way muscles and fat use that glucose. The result can be higher blood sugar levels, which may cause existing diabetes to worsen or, in some people on long-term therapy, contribute to new-onset diabetes. At the same time, steroids increase appetite and redistribute fat in the body, which can lead to weight gain and the characteristic “moon face” or central fat accumulation seen with prolonged high-dose therapy.

Fluid balance and blood pressure can be affected because some corticosteroids have effects similar to another natural hormone that controls salt and water. That can cause the body to retain salt and water, leading to swelling, higher blood pressure, and changes in potassium levels. The exact degree of this effect depends on which steroid is used and at what dose.

Bones and muscles are vulnerable to the gene-level effects of corticosteroids. Steroids reduce bone formation and increase bone breakdown, lowering bone density over time and raising the risk of fractures. They also encourage the breakdown of muscle protein, which can cause weakness and make it harder to recover from illness or stay active. Skin becomes thinner and more fragile because steroids interfere with the normal production of collagen and skin repair.

Eyes and other organs can be affected too. Long-term steroid use increases the risk of cataracts (clouding of the lens) and high pressure inside the eye (glaucoma). The gut lining may be more prone to irritation, and wounds can heal more slowly because the normal inflammatory steps that help repair tissue are suppressed.

One especially important effect relates to the body’s own steroid production. When someone takes corticosteroids for more than a short period, the adrenal glands reduce their own output of natural cortisol because the body senses the drug is providing enough steroid. If the prescribed drug is stopped suddenly, the body may not be able to produce cortisol fast enough, and the person can develop adrenal insufficiency — a dangerous condition that causes weakness, low blood pressure, and fainting. That is why long courses are usually tapered rather than stopped abruptly.

How likely and how severe these side effects are depends on the dose, how long the drug is used, and the route of administration. Short courses at moderate doses commonly produce temporary effects like mood changes, increased appetite, or a temporary rise in blood sugar, whereas chronic high-dose treatment is much more likely to cause long-term problems such as bone loss, muscle wasting, or adrenal suppression. Local treatments (for example, creams, eye drops, or low-dose inhalers) generally cause fewer whole-body effects because less drug reaches the circulation, but repeated or high-strength local use can still cause systemic problems.

In plain terms, corticosteroids trade powerful, rapid control of inflammation and immune activity for a higher chance of upsetting other body systems. That trade-off is often worth it medically, but it requires careful dosing, the shortest effective duration, and close monitoring by a clinician so that benefits outweigh harms. If you or someone you care for is prescribed corticosteroids, it’s sensible to ask the prescriber which specific side effects to expect, how they will be monitored, and what measures (like bone protection, blood-sugar checks, or a gradual taper) will be put in place.

(Source : ChatGPT)

Corticosteroids are a family of medicines that copy the action of hormones your body makes in the adrenal glands (small glands that sit above your kidneys). In plain terms, they tell the immune system and body tissues to “calm down” when there is inflammation or an overactive immune response. Doctors often call them “steroids” or “glucocorticoids,” but these are the same basic group of drugs used to reduce swelling, redness, and the immune reactions that cause many symptoms. (Cleveland Clinic)

The main health benefit of corticosteroids is that they quickly reduce inflammation. That makes them very useful for a wide range of problems: flare-ups of asthma or chronic lung disease, painful swollen joints from arthritis, allergic reactions, certain skin rashes, autoimmune diseases such as lupus, and reducing swelling around tumours or after some surgeries. Because they tamp down immune activity, they can also prevent the immune system from damaging the body in autoimmune conditions. In some cases doctors give a one-time or short course of corticosteroids to bring symptoms down fast; in other cases a carefully controlled longer course is needed to manage a chronic illness. (PMC)

Corticosteroids come in many forms so the medicine is delivered where it’s needed. You can have pills for whole-body effects, injections directly into a joint or muscle for local pain relief, inhalers for lungs, eye drops, creams for skin problems, or IV doses in hospital for severe illness. Choosing the right form helps get the benefit while trying to limit side effects — for example, an inhaler acts mostly in the lungs and usually causes fewer whole-body effects than a high-dose pill. (Mayo Clinic)

Like any powerful medicine, corticosteroids have downsides when they are used often or at high doses. Short-term side effects can include a rise in blood sugar, mood changes, fluid retention, and increased appetite. Longer-term use can weaken bones (osteoporosis), raise infection risk, thin the skin, cause muscle weakness, or lead to weight gain and features of Cushing’s syndrome. Because they suppress the body’s own steroid production, stopping long courses suddenly can be harmful, so doctors usually reduce the dose slowly when a patient finishes a long treatment. These risks are why doctors aim to use the lowest effective dose for the shortest necessary time and why they monitor patients who need ongoing therapy. (NCBI)

In short, corticosteroids are very useful medicines that can be life-changing or life-saving by controlling inflammation and excessive immune reactions, but they must be used carefully because of potential side effects. If you or someone you care for is prescribed corticosteroids, it’s reasonable to ask the prescriber about the specific goal of treatment, which form and dose will be used, how long it will last, what side effects to watch for, and whether anything (like calcium/vitamin D, bone checks, or infection precautions) should be done alongside treatment. (apps.nhslothian.scot)

(Source : ChatGPT)

There isn’t a one-size-fits-all “best” drug — but for most people the safest, most broadly useful single choice is usually dupilumab; if you (or your doctor) need the fastest and largest skin improvement and you are otherwise at low cardiovascular/infection risk, an oral JAK inhibitor (for example upadacitinib or abrocitinib) is often the most potent option over the first 12–16 weeks. (Académie Américaine de Dermatologie)

Why I say that: dupilumab has the longest track record, widespread guideline support and broad approvals (including in young children) and treats related allergic problems like asthma—making it a go-to when safety, durability and treatment of comorbid allergic disease matter. (Jaad) By contrast, recent network meta-analyses show that oral JAK1 inhibitors such as upadacitinib and abrocitinib produce some of the largest short-term gains in skin scores and itch relief, so they’re often chosen when rapid, strong control is the priority. (PMC)

Important safety tradeoffs: JAK inhibitors carry regulatory boxed warnings and real concerns about serious infections, thrombosis, certain cardiovascular events and malignancy in higher-risk populations, so they require careful patient selection and monitoring (age, smoking, prior cancer, heart disease, thrombotic risk, latent TB and vaccination status all matter). If any of those risks are present, biologics like dupilumab (or the IL-13 antibodies tralokinumab/lebrikizumab) are generally favored. (U.S. Food and Drug Administration)

Other options to know about: tralokinumab and lebrikizumab (IL-13 blockers) look broadly similar to dupilumab in trials for many patients and may be chosen for individual reasons (dosing preferences, side-effect profiles, prior response). Nemolizumab is a newer option that specifically targets IL-31 signalling and can be especially helpful when itch is the dominant, hard-to-control symptom. (MDPI)

So if you force me to pick one drug without knowing your age, medical history, other conditions, smoking status, pregnancy plans or prior treatments: dupilumab is the safest “first single pick” for most patients because of its efficacy, long-term safety data and broad approvals. If you want the fastest, largest short-term result and your doctor confirms you’re a low-risk candidate who will be monitored, a JAK inhibitor (e.g., upadacitinib) is the alternative I’d consider. Whatever you do, discuss these tradeoffs with a dermatologist or your prescribing clinician so they can choose the right drug for your specific risks and goals. (Jaad)

(Source : ChatGPT)

Inflammation in eczema and psoriasis is driven by different immune “conversations” in the skin — signals that tell immune cells and skin cells what to do — and those different conversations explain why the two conditions look and feel different.

In eczema (also called atopic dermatitis) the dominant conversation is a type 2 immune response. Skin cells that are stressed or damaged release alarm signals such as TSLP, IL-25 and IL-33. Those signals recruit and activate immune cells that make type 2 cytokines, especially IL-4 and IL-13. These cytokines do several things at once: they weaken how skin cells mature and make barrier lipids, they reduce the skin’s antimicrobial defenses, and they increase itch by acting on nerve-related pathways.

The combined result is a leaky, dry barrier that is easily irritated and intensely itchy, and the itch itself feeds more inflammation because scratching damages the skin further.

Psoriasis runs on a different dominant axis, centered on the IL-23 → Th17 → IL-17 family pathway. In that process, triggers such as mechanical injury, microbes or innate immune activation cause dendritic cells to release IL-23, which helps Th17 cells and other IL-17–producing cells expand and stay active. IL-17 and related cytokines tell keratinocytes (the main skin cells) to multiply and to produce more inflammatory molecules, creating the thick, scaly, red plaques that are characteristic of psoriasis.

Those same cytokines also recruit other immune cells and create a self-reinforcing loop of inflammation and rapid skin turnover.

Although the Th2 (type 2) picture fits eczema and the Th17/IL-23 picture fits psoriasis, reality is not strictly black and white. Other pathways — for example Th22, Th1 and innate immune signals — can be involved in both diseases to varying degrees, and some patients show mixed features. That is one reason why doctors sometimes see overlapping signs and why treatments are increasingly chosen by which molecular signals are most active in a person’s skin rather than by appearance alone.

Understanding these signalling pathways matters because modern therapies directly target them. Blocking IL-4 and IL-13 reduces the harmful type 2 signals in eczema, which helps the barrier recover and reduces itch. In psoriasis, drugs that interrupt IL-23 or IL-17 break the cycle that drives keratinocyte overgrowth and inflammation, often clearing plaques quickly.

To picture it simply: in eczema the skin is hearing a persistent “calm down and repair me” type-2 alarm that instead weakens the barrier and creates itch; in psoriasis the skin is hearing a “grow and defend” Th17 alarm that pushes keratinocytes to overproduce and inflames the area.

Both are inflammatory signalling networks that start with triggers at the skin surface and end in cycles of damage and immune activation — which is why effective care can include both calming immune signals and repairing the skin barrier.

For eczema (atopic dermatitis): dupilumab, tralokinumab, lebrikizumab, nemolizumab, abrocitinib, upadacitinib, baricitinib; topical treatments include corticosteroids, tacrolimus, pimecrolimus, and crisaborole.

For psoriasis: methotrexate, cyclosporine, acitretin, apremilast, adalimumab, etanercept, infliximab, ustekinumab, guselkumab, risankizumab, tildrakizumab, secukinumab, ixekizumab, brodalumab, and bimekizumab.

(Source : Wordpress)

Short answer: some foods contain the kinds of fats and building blocks that help skin make healthy lipids, and eating a balanced diet that includes those foods can support skin health — but eating foods alone is not a quick substitute for topical barrier repair or medical treatment. The effect of dietary lipids on eczema and psoriasis is real but typically modest, variable between people, and best seen as one part of a broader plan rather than a stand-alone cure. (PMC)

To make sense of this, it helps to separate two ways lipids reach your skin. One way is from the outside: creams and lotions deliver ceramides and other barrier lipids directly to the skin surface, and those topical, “tri-lipid” (ceramide:cholesterol:fatty acid) formulations have good clinical evidence for helping restore the skin barrier in people with eczema. That is why many dermatologists recommend ceramide-containing moisturizers as a first-line, everyday measure for dry, inflamed skin. (PMC)

The other way is from the inside: the fats and fatty-acid building blocks you eat can influence what the skin makes. Foods high in long-chain omega-3s — oily fish such as salmon, mackerel, sardines, plus algae or fish-oil supplements that provide EPA and DHA — have been studied because they reduce some forms of inflammation. Clinical reviews show some modest benefit of omega-3s for inflammatory skin conditions (including psoriasis and atopic dermatitis) in some people, but results are mixed and benefits are generally smaller and slower than what you get from targeted topical or prescription therapies. (Journal de Dermatologie Intégrative)

Certain dietary fats are especially important for the physical barrier. Linoleic acid, an essential omega-6 fatty acid that the body cannot make, is a raw material the skin uses when building special lipids (including ω-hydroxy-ceramides) that keep the barrier tight. Low dietary linoleic acid can harm barrier function; in other words, getting enough of these essential fatty acids in the diet supports the skin’s ability to hold onto water and resist irritation. (PMC)

You’ll also see claims about “dietary ceramides” or phytoceramides (from wheat, rice, soy, dairy and eggs). these foods do contain ceramide molecules or precursors, but the amounts in a normal diet are relatively small and the evidence that eating those foods repairs the skin barrier to the same degree as applying ceramide-containing creams is limited. Some supplements that concentrate phytoceramides are marketed for skin hydration, but the science is less robust than the data for topical barrier creams. (HUM Nutrition)

There are also specific supplements that people try for eczema, such as evening primrose oil or borage oil (sources of gamma-linolenic acid). High-quality systematic reviews have generally not found clear benefit of evening primrose or borage oil for eczema over placebo. That doesn’t mean they are always useless, but it does mean they’re not a reliable, evidence-backed fix for most people. If you’re considering supplements, it’s wise to discuss them with your clinician because doses, quality, interactions and side effects matter. (PubMed)

Putting this into everyday terms: eating a balanced, unprocessed diet that includes oily fish, seeds, nuts, whole grains, eggs, dairy if tolerated, and healthy cooking fats like olive oil will supply the essential fatty acids and other nutrients your skin needs to function well. That nutritional support can reduce inflammation and help the skin make healthier lipids over time. However, when the skin barrier is already broken and you have active eczema or psoriasis patches, topical barrier repair (ceramide-containing emollients) and medical anti-inflammatory treatments are typically the fastest and most reliable ways to reduce symptoms. Diet is supportive rather than curative. (Journal de Dermatologie Intégrative)

If you want practical next steps, consider gently increasing oily fish and plants high in essential fatty acids, avoid extreme restrictive diets unless supervised, and talk with your dermatologist or primary care clinician before starting concentrated supplements (especially if you take other medicines). They can help you weigh the likely benefit, choose reputable products, and combine dietary measures with proven topical or prescription therapies for the best results.

(Source : ChatGPT)

Ceramide-containing regimens are simply skin-care plans that use products formulated with ceramides — the natural fats your skin needs to build a strong outer barrier — together with other lipids that the skin normally makes. Ceramides are one of the main types of lipids in the outermost layer of skin, and when you put them on the skin in the right way and combination they help “fill in the gaps” between skin cells so the barrier can hold on to water and keep irritants out. Clinical reviews and trials have found that moisturizers and creams that include ceramides can reduce the severity of atopic dermatitis (eczema) and help restore barrier function. (PMC)

A very common and well-studied approach is a “ceramide-dominant, triple-lipid” formulation. That means the product contains three main kinds of skin lipids: ceramides, cholesterol, and free fatty acids, arranged in a ratio intended to mimic what healthy skin normally has. Some clinical formulations use a 3:1:1 (ceramides:cholesterol:fatty acids) ratio because that mix helps skin make normal lipid layers again and supports the skin’s barrier repair processes. Prescription and over-the-counter products are made this way because the balance between those three lipid types matters for building the right layered structure in the outer skin. (PMC)

When people follow a ceramide-containing regimen they typically use a combination of products chosen to be gentle and supportive. This can include a low-irritant cleanser that doesn’t strip away lipids, a leave-on ceramide-containing moisturizer applied to slightly damp skin to trap water in, and sometimes a thicker ointment or cream for very dry areas or for night use. Some products are sold as specialty “barrier repair” creams and are widely used for eczema; others are everyday moisturizers that list “ceramides” on the ingredient label. Studies show that using these products regularly — alongside any doctor-recommended treatments such as topical anti-inflammatories when needed — improves symptoms and helps the skin stay hydrated and less reactive. (Allure)

There are both over-the-counter options and prescription ceramide-dominant preparations. Popular OTC brands often highlighted by dermatologists include moisturizers and creams that advertise “contains ceramides” and are marketed for dry and sensitive skin; some well known consumer options include lines like CeraVe or Lipikar (La Roche-Posay) and others that combine ceramides with humectants (ingredients that attract water) and occlusives (ingredients that seal moisture in). Prescription products such as EpiCeram were developed specifically to restore the missing lipids in eczema and use the triple-lipid concept in a clinical formulation. The important point is not the brand name but that the formulation contains ceramides plus the complementary lipids and is free of unnecessary irritants (fragrance, strong alcohols) when used for sensitive or inflamed skin. (CeraVe)

How to think about using a ceramide regimen in everyday terms: first, be gentle with cleansing so you don’t strip the skin’s lipids away; second, apply a ceramide-containing moisturizer while the skin is still a little damp so it locks in moisture; third, use the cream consistently (often twice daily for dry skin) rather than only when a flare appears, because maintaining the barrier prevents water loss and reduces triggers. For active, moderate-to-severe eczema or psoriasis you should follow a clinician’s plan — ceramide regimens are a valuable part of care and can reduce the need for stronger medicines in some cases, but they usually work best together with prescription anti-inflammatory treatments when inflammation is high. (Health)

(Source : ChatGPT)

Think of the outermost layer of your skin, the stratum corneum, as a brick wall. The skin cells are the bricks and the lipids — fats like ceramides, cholesterol and free fatty acids — are the mortar that fills the gaps and keeps everything snug. Those lipids form very organized, layered structures that stop water from escaping and keep germs, irritants and allergens out. Without the right lipids in the right arrangement, the “mortar” becomes cracked and leaky. (PubMed Central)

What those lipids actually do is simple but crucial: they hold moisture in, they make the surface less penetrable, and they help the skin recover after small injuries. Ceramides are especially important — they make up a large share of the stratum corneum lipids and are tailored by skin cells to form tight, water-resistant layers. Cholesterol and free fatty acids work together with ceramides to keep those layers stable. If any of these lipid types are missing or out of balance, the barrier becomes weaker. (Wiley Online Library)

When the lipid “mortar” is weakened, two things happen that matter for conditions like eczema and psoriasis. First, more water leaves the skin (this is called increased transepidermal water loss), so the skin dries and becomes more fragile. Second, irritants, microbes and allergens can cross the skin more easily, which can trigger inflammation and immune reactions. That inflammation then makes the skin produce even more defective lipids in a vicious circle. In short: lipid problems → leaky barrier → inflammation and more barrier damage. (PubMed Central)

In eczema (atopic dermatitis), researchers have repeatedly found lower total ceramide levels and changes in specific ceramide types and chain lengths. Those changes make the lipid layers less compact and less able to trap water. People with eczema frequently show higher water loss and greater sensitivity to irritants and allergens, which helps explain why the skin becomes itchy, red and easily infected. Restoring missing lipids is therefore a key part of calming things down and reducing flare-ups. (PubMed Central)

Psoriasis is driven by a different pattern of immune activity, but it also shows disrupted lipid composition. Studies have found altered ceramide content and abnormalities in fatty acids and cholesterol in psoriatic skin, especially in the thick, scaly lesions. Because psoriasis involves very rapid turnover of skin cells, the normal process that builds and arranges lipids is disturbed; that disturbance contributes to the characteristic scale, dryness and cracking, and it can amplify inflammatory signaling. So, even though the root immune causes differ from eczema, lipid dysregulation still plays a meaningful part in how psoriasis looks and feels. (PubMed Central)

What this means in practice is easy to picture: damaged or imbalanced lipids make skin dry, sensitive and more likely to flare. That’s why many clinical and nursing approaches focus not only on reducing inflammation but also on repairing the lipid barrier — for example with moisturizers and formulations that contain ceramides, cholesterol and appropriate fatty acids to help rebuild the “mortar.” Clinical studies and reviews support that ceramide-containing regimens can reduce symptoms and help restore barrier function alongside other treatments. (ScienceDirect)

To sum up in one sentence: lipids are the skin’s essential barrier mortar — when they’re missing, altered, or poorly organized the barrier leaks, water is lost, irritants get in, and immune reactions follow, creating the dry, red, itchy or scaly skin seen in eczema and psoriasis. If you or someone you care for is struggling with these symptoms, a clinician can combine treatments that calm inflammation with sensible barrier repair strategies tailored to the individual. (PubMed Central)

(Source : ChatGPT)